Oncorine (H101)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oncorine (H101), covering 2023-11-18 to 2023-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]